Corporate ActionJul 24, 2026, 10:17 AM
GSK plc Admits 70,759 Ordinary Shares to London Stock Exchange Trading
AI Summary
GSK plc announced the admission of 70,759 ordinary shares to trading on the London Stock Exchange's Main Market. These shares, with a nominal value of 31¼ pence each, are fully fungible with existing ordinary shares. The admission is in connection with the GlaxoSmithKline plc Share Save Plan 2022 and covers the period from May 29, 2026, to July 24, 2026. Following this admission, the total number of ordinary shares admitted to trading is 4,316,292,310.
Key Highlights
- GSK plc admitted 70,759 ordinary shares to trading.
- Shares were admitted on the London Stock Exchange - Main Market.
- The admission is linked to the GlaxoSmithKline plc Share Save Plan 2022.
- Total ordinary shares admitted to trading now stand at 4,316,292,310.
- The newly admitted shares are fully fungible with existing ordinary shares.
- The admission covers the period from May 29, 2026, to July 24, 2026.
Price Impact
More from GSK